BEKINDA
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BEKINDA, covering 2018-07-31 to 2019-02-20. Get the full timeline:
Most recent: Clinical Trial Update: BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis [Phase 3]